ID

28043

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Past medical conditions

Mots-clés

Versions (3)

1. 27/08/2017 27/08/2017 -
2. 23/10/2017 23/10/2017 -
3. 12/12/2017 12/12/2017 -

Détendeur de droits

GlaxoSmithKline

Téléchargé le

12 décembre 2017

DOI

Pour une demande vous connecter.

Licence